The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-7601
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012 ; volume:17 ; number:7 ; day:5 ; month:9 ; year:2015 ; pages:833-854 ; date:9.2016
The European journal of health economics ; 17, Heft 7 (5.9.2015), 833-854, 9.2016
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10198-015-0725-6
- URN
-
urn:nbn:de:1111-201609018469
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T10:43:59+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lichtenberg, Frank R.
- SpringerLink (Online service)
Other Objects (12)
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019
Premature mortality and poverty measurement
Journal of pharmaceutical innovation
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
Economic impacts of a premature nuclear phase-out in Switzerland
Economic Impacts of a Premature Nuclear Phase-Out in Switzerland
Second generation patents in pharmaceutical innovation
Adverse childhood experiences and premature all-cause mortality
A Mixture-Function Mortality Model: Illustration of the Evolution of Premature Mortality
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019
Premature mortality and poverty measurement
Journal of pharmaceutical innovation
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
Economic impacts of a premature nuclear phase-out in Switzerland
Economic Impacts of a Premature Nuclear Phase-Out in Switzerland
Second generation patents in pharmaceutical innovation
Adverse childhood experiences and premature all-cause mortality
A Mixture-Function Mortality Model: Illustration of the Evolution of Premature Mortality
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019
Premature mortality and poverty measurement
Journal of pharmaceutical innovation
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
Economic impacts of a premature nuclear phase-out in Switzerland
Economic Impacts of a Premature Nuclear Phase-Out in Switzerland
Second generation patents in pharmaceutical innovation
Adverse childhood experiences and premature all-cause mortality
A Mixture-Function Mortality Model: Illustration of the Evolution of Premature Mortality